Quality by design with design of experiments approach for the development of a stability‐indicating LC method for benzonatate and its impurities in liquid oral dosage form-Reference-Cited by-同舟云学术

Quality by design with design of experiments approach for the development of a stability‐indicating LC method for benzonatate and its impurities in liquid oral dosage form

Published:2020-05-04 Issue:7 Volume:3 Page:276-285
ISSN:2573-1815
Container-title:SEPARATION SCIENCE PLUS
language:en
Short-container-title:Sep Sci plus

Author:

Katakam Lakshmi Narasimha Rao¹^ORCID,Dongala Thirupathi²^ORCID

Affiliation:

1. Analytical Research and DevelopmentSaptalis Pharmaceuticals LLC New York USA

2. Quality controlAurex Laboratories LLC New Jersey USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sscp.202000023

Reference31 articles.

1. Benzonatate toxicity in a teenager resulting in coma, seizures, and severe metabolic acidosis;Thimann D. A.;J Pediatr Pharmacol Ther,2012

2. Benzonatate Toxicity: Nothing to Cough At

3. U.S. Food and Drug Administration (FDA)FDA Drug Safety Communication: Death resulting from overdose after accidental ingestion of Tessalon (benzonatate) by children under 10 years of age (last time Accessed date: 02/17/2020).

4. STABILITY-INDICATING CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF BENZONATATE, DIPHENHYDRAMINE, GUAIFENESIN, AND PHENYLEPHRINE

5. Degradation kinetics of benzonatate in aqueous solutions

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A brief review on application of design of experiment for the analysis of pharmaceuticals using HPLC;Annales Pharmaceutiques Françaises;2023-12

2. A validated stability‐indicating reversed‐phase‐HPLC method for dipyridamole in the presence of degradation products and its process‐related impurities in pharmaceutical dosage forms;Biomedical Chromatography;2021-10-21

3. Development and validation of a stability‐indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple‐combination dosage form using factorial design of experiments;Biomedical Chromatography;2021-06-28

4. A rapid RP‐HPLC stability‐indicating method development and validation of moxifloxacin hydrochloride–related substances in finished dosage forms;Biomedical Chromatography;2021-06-23

5. A simple and rapid HPLC method for determination of parabens and their degradation products in pharmaceutical dosage forms;Biomedical Chromatography;2021-05-17